Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Nuttall

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Journal of Clinical Pharmacy and Therapeutics|February 16, 2002
The heart protection study: statins for all those at risk?M J Kendall, S L Nuttall
Journal of Clinical Pharmacy and Therapeutics|February 28, 2003
Coronary artery disease--more disease, more patients, better treatmentM J Kendall, S L Nuttall
BMJ (Clinical Research Ed.)|February 25, 2000
beta Blockade after myocardial infarction. Beta blockers have key role in reducing morbidity and mortality after infarctionS L Nuttall, V Toescu, M J Kendall
Journal of Clinical Pharmacy and Therapeutics|September 4, 1999
The incidence of sudden death in post-myocardial infarction beta-blocker trialsS L Nuttall, V Toescu, M J Kendall
Journal of Clinical Pharmacy and Therapeutics|August 13, 2003
Does paracetamol cause asthma?S L Nuttall, J Williams, M J Kendall
Journal of Clinical Pharmacy and Therapeutics|June 11, 2003
Insulin resistance--the new goal!P Peter, S L Nuttall, M J Kendall
QJM : Monthly Journal of the Association of Physicians|January 1, 2000
Antioxidant therapy for the prevention of cardiovascular diseaseS L Nuttall, M J Kendall, U Martin
Journal of Clinical Pharmacy and Therapeutics|August 7, 1999
Angina and its treatmentM J Kendall, V Toescu, S L Nuttall
Journal of Clinical Pharmacy and Therapeutics|January 6, 1999
Antioxidant therapy--a new therapeutic option for reducing mortality from coronary artery diseaseM J Kendall, S L Nuttall, U Martin
Journal of Clinical Pharmacy and Therapeutics|August 9, 2001
Prostate cancer and antioxidantsJ George, S L Nuttall, M J Kendall
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Journal of Clinical Pharmacy and Therapeutics|February 16, 2002
The heart protection study: statins for all those at risk?M J Kendall, S L Nuttall
Journal of Clinical Pharmacy and Therapeutics|February 28, 2003
Coronary artery disease--more disease, more patients, better treatmentM J Kendall, S L Nuttall
BMJ (Clinical Research Ed.)|February 25, 2000
beta Blockade after myocardial infarction. Beta blockers have key role in reducing morbidity and mortality after infarctionS L Nuttall, V Toescu, M J Kendall
Journal of Clinical Pharmacy and Therapeutics|September 4, 1999
The incidence of sudden death in post-myocardial infarction beta-blocker trialsS L Nuttall, V Toescu, M J Kendall
Journal of Clinical Pharmacy and Therapeutics|August 13, 2003
Does paracetamol cause asthma?S L Nuttall, J Williams, M J Kendall
Journal of Clinical Pharmacy and Therapeutics|June 11, 2003
Insulin resistance--the new goal!P Peter, S L Nuttall, M J Kendall
QJM : Monthly Journal of the Association of Physicians|January 1, 2000
Antioxidant therapy for the prevention of cardiovascular diseaseS L Nuttall, M J Kendall, U Martin
Journal of Clinical Pharmacy and Therapeutics|August 7, 1999
Angina and its treatmentM J Kendall, V Toescu, S L Nuttall
Journal of Clinical Pharmacy and Therapeutics|January 6, 1999
Antioxidant therapy--a new therapeutic option for reducing mortality from coronary artery diseaseM J Kendall, S L Nuttall, U Martin
Journal of Clinical Pharmacy and Therapeutics|August 9, 2001
Prostate cancer and antioxidantsJ George, S L Nuttall, M J Kendall
Pageof 4